GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (LTS:0A8L) » Definitions » Cyclically Adjusted PB Ratio

OpGen (LTS:0A8L) Cyclically Adjusted PB Ratio : 0.00 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is OpGen Cyclically Adjusted PB Ratio?

As of today (2024-05-21), OpGen's current share price is $5.087. OpGen's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $60,093.80. OpGen's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for OpGen's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0A8L's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.14
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

OpGen's adjusted book value per share data for the three months ended in Sep. 2023 was $2.673. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $60,093.80 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


OpGen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for OpGen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OpGen Cyclically Adjusted PB Ratio Chart

OpGen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OpGen Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OpGen's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, OpGen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OpGen's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where OpGen's Cyclically Adjusted PB Ratio falls into.



OpGen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

OpGen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.087/60093.8
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OpGen's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, OpGen's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.673/129.8595*129.8595
=2.673

Current CPI (Sep. 2023) = 129.8595.

OpGen Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.000 98.326 0.000
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 -73,327.273 99.070 -96,116.603
201503 -80,127.273 99.621 -104,448.632
201506 80,254.545 100.684 103,510.244
201509 99,541.667 100.392 128,760.215
201512 62,425.000 99.792 81,233.433
201603 27,125.000 100.470 35,059.470
201606 41,694.737 101.688 53,245.736
201609 14,886.364 101.861 18,978.174
201612 12,668.000 101.863 16,149.780
201703 2,051.852 102.862 2,590.383
201706 -7,372.414 103.349 -9,263.535
201709 7,230.769 104.136 9,016.936
201712 2,457.895 104.011 3,068.721
201803 7,045.455 105.290 8,689.558
201806 4,209.868 106.317 5,142.098
201809 2,503.106 106.507 3,051.940
201812 1,531.944 105.998 1,876.806
201903 983.900 107.251 1,191.312
201906 414.286 108.070 497.818
201909 -353.061 108.329 -423.231
201912 153.816 108.420 184.232
202003 225.906 108.902 269.381
202006 211.699 108.767 252.752
202009 172.515 109.815 204.004
202012 168.947 109.897 199.636
202103 240.584 111.754 279.561
202106 207.661 114.631 235.248
202109 174.021 115.734 195.260
202112 177.468 117.630 195.919
202203 146.789 121.301 157.146
202206 117.369 125.017 121.915
202209 57.669 125.227 59.803
202212 26.125 125.222 27.093
202303 16.699 127.348 17.028
202306 9.845 128.729 9.931
202309 2.673 129.860 2.673

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OpGen  (LTS:0A8L) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


OpGen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of OpGen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OpGen (LTS:0A8L) Business Description

Traded in Other Exchanges
Address
9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

OpGen (LTS:0A8L) Headlines

No Headlines